{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T06:53:57Z","timestamp":1779000837196,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T00:00:00Z","timestamp":1539561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T00:00:00Z","timestamp":1539561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Dihydroartemisinin (DHA) and its analogs are reported to possess selective anticancer activity. Here, we reported a novel DHA derivative DHA-37 that exhibited more potent anticancer activity on the cells tested. Distinct from DHA-induced apoptosis, DHA-37 triggered excessive autophagic cell death, and became the main contributor to DHA-37-induced A549 cell death. Incubation of the cells with DHA-37 but not DHA produced increased dots distribution of GFP-LC3 and expression ratio of LC3-II\/LC3-I, and enhanced the formation of autophagic vacuoles as revealed by TEM. Treatment with the autophagy inhibitor 3-MA, LY294002, or chloroquine could reverse DHA-37-induced cell death. In addition, DHA-37-induced cell death was associated significantly with the increased expression of HMGB1, and knockdown of HMGB1 could reverse DHA-37-induced cell death. More importantly, the elevated HMGB1 expression induced autophagy through the activation of the MAPK signal but not PI3K-AKT\u2013mTOR pathway. In addition, DHA-37 also showed a wonderful performance in A549 xenograft mice model. These findings suggest that HMGB1 as a target candidate for apoptosis-resistant cancer treatment and artemisinin-based drugs could be used in inducing autophagic cell death.<\/jats:p>","DOI":"10.1038\/s41419-018-1006-y","type":"journal-article","created":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T08:42:30Z","timestamp":1539592950000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Novel dihydroartemisinin derivative DHA-37 induces autophagic cell death through upregulation of HMGB1 in A549 cells"],"prefix":"10.1038","volume":"9","author":[{"given":"Xiufeng","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juanjuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Menglin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenling","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yini","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Hua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo-Yang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,15]]},"reference":[{"key":"1006_CR1","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S2213-2600(13)70009-2","volume":"1","author":"G Stella","year":"2013","unstructured":"Stella, G., Luisetti, M., Pozzi, E. & Comoglio, P. Oncogenes in non-small-cell lung cancer: emerging connections and novel therapeutic dynamics. Lancet Respir. Med. 1, 251\u2013261 (2013).","journal-title":"Lancet Respir. Med."},{"key":"1006_CR2","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nrc3775","volume":"14","author":"Z Chen","year":"2014","unstructured":"Chen, Z., Fillmore, C. M., Hammerman, P. S., Kim, C. F. & Wong, K. K. Non-small-cell lung cancers: a heterogeneous set of diseases. Nat. Rev. Cancer 14, 535\u2013546 (2014).","journal-title":"Nat. Rev. Cancer"},{"key":"1006_CR3","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0165-6147(99)01302-4","volume":"20","author":"MA van Agtmael","year":"1999","unstructured":"van Agtmael, M. A., Eggelte, T. A. & van Boxtel, C. J. Artemisinin drugs in the treatment of malaria: from medicinal herb to registered medication. Trends Pharmacol. Sci. 20, 199\u2013205 (1999).","journal-title":"Trends Pharmacol. Sci."},{"key":"1006_CR4","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/nm.2471","volume":"17","author":"Y Tu","year":"2011","unstructured":"Tu, Y. The discovery of artemisinin (qinghaosu) and gifts from chinese medicine. Nat. Med. 17, 1217\u20131220 (2011).","journal-title":"Nat. Med."},{"key":"1006_CR5","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s10637-012-9873-z","volume":"31","author":"HC Lai","year":"2013","unstructured":"Lai, H. C., Singh, N. P. & Sasaki, T. Development of artemisinin compounds for cancer treatment. Invest. New Drugs 31, 230\u2013246 (2013).","journal-title":"Invest. New Drugs"},{"key":"1006_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.semcancer.2017.02.009","volume":"46","author":"T Efferth","year":"2017","unstructured":"Efferth, T. From ancient herb to modern drug: Artemisia annua and artemisinin for cancer therapy. Semin. Cancer Biol. 46, 65\u201383 (2017).","journal-title":"Semin. Cancer Biol."},{"key":"1006_CR7","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.ejmech.2016.08.015","volume":"123","author":"CC Xu","year":"2016","unstructured":"Xu, C.-C. et al. Synthesis and cytotoxicity of novel artemisinin derivatives containing sulfur atoms. Eur. J. Med. Chem. 123, 763\u2013768 (2016).","journal-title":"Eur. J. Med. Chem."},{"key":"1006_CR8","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ejmech.2015.11.003","volume":"107","author":"CC Xu","year":"2016","unstructured":"Xu, C.-C. et al. Synthesis and in vitro antitumor evaluation of dihydroartemisinin-cinnamic acid ester derivatives. Eur. J. Med. Chem. 107, 192\u2013203 (2016).","journal-title":"Eur. J. Med. Chem."},{"key":"1006_CR9","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/nrc3599","volume":"13","author":"C Holohan","year":"2013","unstructured":"Holohan, C., Van Schaeybroeck, S., Longley, D. B. & Johnston, P. G. Cancer drug resistance: an evolving paradigm. Nat. Rev. Cancer 13, 714\u2013726 (2013).","journal-title":"Nat. Rev. Cancer"},{"issue":"Basel","key":"1006_CR10","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.3390\/cancers6031769","volume":"6","author":"G Housman","year":"2014","unstructured":"Housman, G. et al. Drug resistance in cancer: an overview. Cancers 6(Basel), 1769\u20131792 (2014).","journal-title":"Cancers"},{"key":"1006_CR11","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.1016\/j.semcancer.2015.03.001","volume":"35","author":"RM Mohammad","year":"2015","unstructured":"Mohammad, R. M. et al. Broad targeting of resistance to apoptosis in cancer. Semin. Cancer Biol. 35, S78\u2013S103 (2015).","journal-title":"Semin. Cancer Biol."},{"key":"1006_CR12","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1158\/1535-7163.MCT-13-1043","volume":"13","author":"B Zhai","year":"2014","unstructured":"Zhai, B. et al. Inhibition of akt reverses the acquired resistance to sorafenib by switching protective autophagy to autophagic cell death in hepatocellular carcinoma. Mol. Cancer Ther. 13, 1589\u20131598 (2014).","journal-title":"Mol. Cancer Ther."},{"key":"1006_CR13","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.3390\/ijms15023145","volume":"15","author":"S Shimizu","year":"2014","unstructured":"Shimizu, S., Yoshida, T., Tsujioka, M. & Arakawa, S. Autophagic cell death and cancer. Int. J. Mol. Sci. 15, 3145\u20133153 (2014).","journal-title":"Int. J. Mol. Sci."},{"key":"1006_CR14","doi-asserted-by":"crossref","unstructured":"Law, B. Y. K. et al. Natural small-molecule enhancers of autophagy induce autophagic cell death in apoptosis-defective cells. Sci. Rep. 4, 5510 (2014).","DOI":"10.1038\/srep05510"},{"key":"1006_CR15","doi-asserted-by":"crossref","first-page":"30077","DOI":"10.18632\/oncotarget.15616","volume":"8","author":"BYK Law","year":"2017","unstructured":"Law, B. Y. K. et al. Thalidezine, a novel ampk activator, eliminates apoptosis-resistant cancer cells through energy-mediated autophagic cell death. Oncotarget 8, 30077\u201330091 (2017).","journal-title":"Oncotarget"},{"key":"1006_CR16","doi-asserted-by":"publisher","first-page":"8090","DOI":"10.18632\/oncotarget.6980","volume":"7","author":"BYK Law","year":"2016","unstructured":"Law, B. Y. K. et al. Hernandezine, a novel ampk activator induces autophagic cell death in drug-resistant cancers. Oncotarget 7, 8090\u20138104 (2016).","journal-title":"Oncotarget"},{"key":"1006_CR17","doi-asserted-by":"publisher","first-page":"904","DOI":"10.4161\/auto.7.8.15704","volume":"7","author":"R Kang","year":"2011","unstructured":"Kang, R., Livesey, K. M., Zeh, H. J. III, Lotze, M. T. & Tang, D. Hmgb1 as an autophagy sensor in oxidative stress. Autophagy 7, 904\u2013906 (2011).","journal-title":"Autophagy"},{"key":"1006_CR18","doi-asserted-by":"publisher","first-page":"451","DOI":"10.4161\/auto.23691","volume":"9","author":"Q Zhang","year":"2013","unstructured":"Zhang, Q., Kang, R., Zeh, H. J. III, Lotze, M. T. & Tang, D. Damps and autophagy cellular adaptation to injury and unscheduled cell death. Autophagy 9, 451\u2013458 (2013).","journal-title":"Autophagy"},{"key":"1006_CR19","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.4161\/auto.6.8.13367","volume":"6","author":"D Tang","year":"2010","unstructured":"Tang, D., Lotze, M. T., Zeh, H. J. & Kang, R. The redox protein hmgb1 regulates cell death and survival in cancer treatment. Autophagy 6, 1181\u20131183 (2010).","journal-title":"Autophagy"},{"key":"1006_CR20","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.4161\/auto.32184","volume":"10","author":"X Sun","year":"2014","unstructured":"Sun, X. & Tang, D. Hmgb1-dependent and -independent autophagy. Autophagy 10, 1873\u20131876 (2014).","journal-title":"Autophagy"},{"key":"1006_CR21","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1083\/jcb.200911078","volume":"190","author":"D Tang","year":"2010","unstructured":"Tang, D. et al. Endogenous hmgb1 regulates autophagy. J. Cell. Biol. 190, 881\u2013892 (2010).","journal-title":"J. Cell. Biol."},{"key":"1006_CR22","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.4161\/auto.6.8.13651","volume":"6","author":"R Kang","year":"2010","unstructured":"Kang, R., Livesey, K. M., Zeh, H. J., Lotze, M. T. & Tang, D. Hmgb1 a novel beclin 1-binding protein active in autophagy. Autophagy 6, 1209\u20131211 (2010).","journal-title":"Autophagy"},{"key":"1006_CR23","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1080\/15548627.2015.1054595","volume":"11","author":"X Sun","year":"2015","unstructured":"Sun, X. & Tang, D. Hepatocyte-specific hmgb1 deletion. Autophagy 11, 1189\u20131191 (2015).","journal-title":"Autophagy"},{"key":"1006_CR24","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.cmet.2014.01.014","volume":"19","author":"P Huebener","year":"2014","unstructured":"Huebener, P. et al. High-mobility group box 1 is dispensable for autophagy, mitochondrial quality control, and organ function in vivo. Cell. Metab. 19, 539\u2013547 (2014).","journal-title":"Cell. Metab."},{"key":"1006_CR25","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1080\/15548627.2015.1054593","volume":"11","author":"P Huebener","year":"2015","unstructured":"Huebener, P., Gwak, G. Y. & Schwabe, R. F. Comment on: Hmgb1-dependent and -independent autophagy. Autophagy 11, 1187\u20131188 (2015).","journal-title":"Autophagy"},{"key":"1006_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15548627.2015.1100356","volume":"12","author":"DJ Klionsky","year":"2016","unstructured":"Klionsky, D. J. et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition. Autophagy 12, 1\u2013222 (2016).","journal-title":"Autophagy"},{"key":"1006_CR27","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.cell.2009.05.023","volume":"137","author":"J Moscat","year":"2009","unstructured":"Moscat, J. & Diaz-Meco, M. T. P62 at the crossroads of autophagy, apoptosis, and cancer. Cell 137, 1001\u20131004 (2009).","journal-title":"Cell"},{"key":"1006_CR28","doi-asserted-by":"crossref","unstructured":"Yu, Y., Tang, D. & Kang, R. Oxidative stress-mediatedhmgb1 biology. Front. Physiol. 6, 93 (2015).","DOI":"10.3389\/fphys.2015.00093"},{"key":"1006_CR29","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1089\/ars.2010.3666","volume":"15","author":"D Tang","year":"2011","unstructured":"Tang, D., Kang, R., Livesey, K. M., Zeh, H. J. III & Lotze, M. T. High mobility group box 1 (hmgb1) activates an autophagic response to oxidative stress. Antioxid. Redox Signal. 15, 2185\u20132195 (2011).","journal-title":"Antioxid. Redox Signal."},{"issue":"5","key":"1006_CR30","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.3390\/ijms18051088","volume":"18","author":"Kwang-Youn Kim","year":"2017","unstructured":"Kim, K.-Y. et al. Inhibition of autophagy promotes salinomycin-induced apoptosis via reactive oxygen species-mediated pi3k\/akt\/mtor and erk\/p38 mapk-dependent signaling in human prostate cancer cells. Int. J. Mol. Sci. 18, E1088 (2017).","journal-title":"International Journal of Molecular Sciences"},{"key":"1006_CR31","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.etap.2016.06.005","volume":"45","author":"Varadharajan Thiyagarajan","year":"2016","unstructured":"Thiyagarajan, V., Sivalingam, K. S., Viswanadha, V. P. & Weng, C.-F. 16-hydroxy-cleroda-3,13-dien-16,15-olide induced glioma cell autophagy via ros generation and activation of p38 mapk and erk-1\/2. Environ. Toxicol. Pharmacol. 45, 202\u2013211 (2016).","journal-title":"Environmental Toxicology and Pharmacology"},{"key":"1006_CR32","doi-asserted-by":"crossref","unstructured":"Xu, S. et al. The liver protection of propylene glycol alginate sodium sulfate preconditioning against ischemia reperfusion injury: focusing mapk pathway activity. Sci. Rep. 7, 15175 (2017).","DOI":"10.1038\/s41598-017-15521-3"},{"key":"1006_CR33","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1128\/AAC.00609-07","volume":"52","author":"MdP Crespo","year":"2008","unstructured":"Crespo, Md. P. et al. Artemisinin and a series of novel endoperoxide antimalarials exert early effects on digestive vacuole morphology. Antimicrob. Agents Chemother. 52, 98\u2013109 (2008).","journal-title":"Antimicrob. Agents Chemother."},{"key":"1006_CR34","doi-asserted-by":"crossref","unstructured":"Crespo-Ortiz, M. P. & Wei, M. Q. Antitumor activity of artemisinin and its derivatives: from a well-known antimalarial agent to a potential anticancer drug. J. Biomed. Biotechnol. 2012, 247597 (2012).","DOI":"10.1155\/2012\/247597"},{"key":"1006_CR35","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1016\/j.bmcl.2011.03.090","volume":"21","author":"TS Feng","year":"2011","unstructured":"Feng, T.-S. et al. Antiplasmodial and antitumor activity of dihydroartemisinin analogs derived via the aza-michael addition reaction. Bioorg. Med. Chem. Lett. 21, 2882\u20132886 (2011).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"1006_CR36","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1167\/iovs.12-11068","volume":"54","author":"R Cheng","year":"2013","unstructured":"Cheng, R. et al. The artemisinin derivative artesunate inhibits corneal neovascularization by inducing ros-dependent apoptosis in vascular endothelial cells. Invest. Ophthalmol. Vis. Sci. 54, 3400\u20133409 (2013).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"1006_CR37","first-page":"8684","volume":"7","author":"K Liao","year":"2014","unstructured":"Liao, K., Li, J. & Wang, Z. Dihydroartemisinin inhibits cell proliferation via akt\/gsk3 beta\/cyclind1 pathway and induces apoptosis in a549 lung cancer cells. Int. J. Clin. Exp. Pathol. 7, 8684\u20138691 (2014).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"1006_CR38","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jnutbio.2016.09.006","volume":"39","author":"Z Tylichova","year":"2017","unstructured":"Tylichova, Z. et al. Activation of autophagy and ppar gamma protect colon cancer cells against apoptosis induced by interactive effects of butyrate and dha in a cell type-dependent manner: the role of cell differentiation. J. Nutr. Biochem. 39, 145\u2013155 (2017).","journal-title":"J. Nutr. Biochem."},{"key":"1006_CR39","doi-asserted-by":"crossref","first-page":"28851","DOI":"10.18632\/oncotarget.4767","volume":"6","author":"JP Tsai","year":"2015","unstructured":"Tsai, J.-P. et al. Licochalcone a induces autophagy through pi3k\/akt\/mtor inactivation and autophagy suppression enhances licochalcone a-induced apoptosis of human cervical cancer cells. Oncotarget 6, 28851\u201328866 (2015).","journal-title":"Oncotarget"},{"key":"1006_CR40","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1016\/j.bbamcr.2016.09.015","volume":"1863","author":"M Redza-Dutordoir","year":"2016","unstructured":"Redza-Dutordoir, M., Kassis, S., Ve, H., Grondin, M. & Averill-Bates, D. A. Inhibition of autophagy sensitises cells to hydrogen peroxide-induced apoptosis: protective effect of mild thermotolerance acquired at 40 degrees c. Biochim. Biophys. Acta 1863, 3050\u20133064 (2016).","journal-title":"Biochim. Biophys. Acta"},{"key":"1006_CR41","doi-asserted-by":"publisher","first-page":"E155","DOI":"10.1073\/pnas.1522288113","volume":"113","author":"A Bangert","year":"2016","unstructured":"Bangert, A. et al. Critical role of rage and hmgb1 in inflammatory heart disease. Proc. Natl Acad. Sci. USA 113, E155\u2013E164 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1006_CR42","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/cr.2017.51","volume":"27","author":"R Kang","year":"2017","unstructured":"Kang, R. et al. Intracellular hmgb1 as a novel tumor suppressor of pancreatic cancer. Cell Res. 27, 916\u2013932 (2017).","journal-title":"Cell Res."},{"key":"1006_CR43","doi-asserted-by":"publisher","first-page":"20699","DOI":"10.1073\/pnas.1320808110","volume":"110","author":"H Yanai","year":"2013","unstructured":"Yanai, H. et al. Conditional ablation of hmgb1 in mice reveals its protective function against endotoxemia and bacterial infection. Proc. Natl Acad. Sci. USA 110, 20699\u201320704 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1006_CR44","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1016\/j.cellsig.2014.08.019","volume":"26","author":"D Heras-Sandoval","year":"2014","unstructured":"Heras-Sandoval, D., Perez-Rojas, J. M., Hernandez-Damian, J. & Pedraza-Chaverri, J. The role of pi3k\/akt\/mtor pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration. Cell. Signal. 26, 2694\u20132701 (2014).","journal-title":"Cell. Signal."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1006-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1006-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1006-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:24:02Z","timestamp":1671539042000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1006-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,15]]},"references-count":44,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,11]]}},"alternative-id":["1006"],"URL":"https:\/\/doi.org\/10.1038\/s41419-018-1006-y","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,15]]},"assertion":[{"value":"29 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"1048"}}